---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023975"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2023-07-07T23:59:59+00:00"
generated_at: "2026-06-13T11:06:59.499718+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AgeX Therapeutics draws $500,000 under secured convertible note due Feb 2024

## Summary
- Drew $500,000 from credit available under Secured Note on July 5, 2023.
- Outstanding principal balance due and payable on February 14, 2024.
- Other material terms of the Secured Note previously filed in Form 10-Q and Form 8-K.

## SEC filing metadata
- accession: 0001493152-23-023975
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2023-07-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 2.03, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315223023975/0001493152-23-023975-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223023975/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023975
- JSON: https://secwatch.observer/filing/0001493152-23-023975.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023975.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred convertible notes of $500,000 maturing February 14, 2024.
  - Instrument: convertible notes
  - Principal: $500,000
  - Maturity: February 14, 2024
  - Event: incurrence
  source text: On July 5, 2023, AgeX drew $500,000 of its credit available under the Allonge and Restated Convertible Promissory Note (“Secured Note”) as amended on June 2, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315223023975/0001493152-23-023975-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.